Table III.
RBM47 expression in patients with NSCLC and its associations with different characteristics.
| RBM47 expression | ||||
|---|---|---|---|---|
| Variables | Patient, n | Negative expression, n (%) | Positive expression, n (%) | P-valuea |
| Tissues | <0.001 | |||
| Normal lung tissues | 175 | 137 (78.3) | 38 (21.7) | |
| Primary tumors of NSCLC | 175 | 43 (24.6) | 132 (75.4) | |
| Sex | 0.329 | |||
| Male | 107 | 29 (27.1) | 78 (72.9) | |
| Female | 68 | 14 (20.6) | 54 (79.4) | |
| Age, years | 0.125 | |||
| <60 | 99 | 20 (20.2) | 79 (79.8) | |
| ≥60 | 76 | 23 (30.3) | 53 (69.7) | |
| Pathological type | <0.001 | |||
| Adenocarcinoma | 131 | 21 (16.0) | 110 (84.0) | |
| Squamous carcinoma | 44 | 22 (50.0) | 22 (59.0) | |
| Tumor size (pT stage) | 0.784 | |||
| T1 | 94 | 25 (26.6) | 69 (73.4) | |
| T2 | 60 | 13 (21.7) | 47 (73.8) | |
| T3/T4 | 21 | 5 (23.8) | 16 (76.2) | |
| Lymph node metastasis (pN stage) | 0.578 | |||
| Negative | 104 | 24 (23.1) | 80 (76.9) | |
| Positive | 71 | 19 (26.8) | 52 (73.2) | |
| AJCC stage at diagnosis | 0.366 | |||
| I | 86 | 19 (22.1) | 67 (77.9) | |
| II | 34 | 12 (35.3) | 24 (64.7) | |
| IIIA | 55 | 12 (21.8) | 43 (78.2) | |
a
According to the χ2 test. RBM47, RNA-binding motif protein 47; NSCLC, non-small cell lung cancer; pT, pathological tumor size; pN, pathological lymph node stage; AJCC, American Joint Committee on Cancer.